TABLE 3

Baseline characteristics of blood eosinophil longitudinal patterns in patients with chronic obstructive pulmonary disease (BODE cohort) using ≥300 cells·μL–1 as the cut-off point

Persistently high ≥300 cells·μL–1Intermittently variablePersistently low <300 cells·μL–1p-value
Patients n3893177
Male30 (79)76 (82)143 (81)0.930
Age years63±866±965±90.386
Pack-years64±3359±3061±330.701
Active smoking4233290.298
BMI kg·m−228.2±6.128.2±4.927.8±4.70.655
FEV1 L1.58±0.531.52±0.561.56±0.680.877
FEV1 % pred60±1860±2259±220.959
FVC L2.92±0.763.02±0.802.98±0.850.839
FVC % pred84±1884±2285±240.874
FEV1/FVC53±1251±1350±130.289
6MWD m397±131379±132418±1150.058
Dyspnoea mMRC1 (0–4)1 (0–4)1 (0–3)0.340
BODE index1 (0–7)1 (0–6)1 (0–6)0.384
IC/TLC0.34±0.050.34±0.110.33±0.110.913
KCO % pred74±2374±2072±200.718
Charlson index2 (0–4)1 (0–5)1 (0–4)0.624
Inhaled anticholinergic6065650.853
Inhaled β2-agonist6558650.529
Inhaled corticosteroid6555580.563

Data presented as n (%), mean±sd, % or median (5th–95th percentile), unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; 6MWD: 6-min walk distance; mMRC: modified Medical Research Council; IC/TLC: inspiratory capacity/total lung capacity; KCO: transfer coefficient of the lung for carbon monoxide.